Navigation Links
Elekta Sees Record Attendance and Record Number of Submitted Abstracts at International Leksell Gamma Knife(R) Society Meeting in Quebec, Canada
Date:5/21/2008

STOCKHOLM, Sweden, May 21 /PRNewswire/ -- At the 14th International Leksell Gamma Knife(R) Society Meeting on May 18-22, over 500 participants including neurosurgeons, radiation oncologists and other medical specialists using Leksell Gamma Knife for treatment of tumors and other brain disorders convened at the historic Chateau Frontenac Hotel in Quebec, Canada. During the meeting, 260 oral and poster presentations covered treatment of malignant and benign brain tumors, functional neurosurgery, imaging and biology as well as physics and technology. Wednesday, May 21, the prestigious Pioneers in Radiosurgery Award was presented to John Flickinger, M.D., Professor of Radiation Oncology and Neurological Surgery at the University of Pittsburgh for his early pioneering work on prediction of complications following Gamma Knife(R) surgery.

(Logo: http://www.newscom.com/cgi-bin/prnh/20020318/ELEKTALOGO )

The Leksell Gamma Knife Society was established in 1989 to provide a forum for Gamma Knife users to share information, experiences, clinical techniques and advanced scientific research in their quest to non-invasively treat an expanding number of brain disorders. The meetings, which are held biannually, result in a large number of clinical publications, in recent years published as a supplement to Journal of Neurosurgery. The Society plays an important role in increasing the visibility and acceptance of Gamma Knife surgery in the worldwide medical community, among healthcare providers and among patients. The open sharing of results and experiences allows all Gamma Knife users to maintain leadership in the field of intracranial radiosurgery, based on the most recent clinical advancements.

The 14th meeting in Quebec is held with the theme, "Je me Souviens ... " ("I Remember ... "), which is the motto of Quebec. The theme connects the celebration of Quebec 400 year lo
'/>"/>

SOURCE Elekta, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Johns Hopkins to add Elekta Synergy S(R) to Cancer Treatment Lineup
2. Elekta Demonstrates Commitment to Stereotactic Innovation at EANS
3. Elekta To Showcase Innovations in Radiotherapy and Unveil New Product That Expands Cancer Treatment Availability
4. Elekta Contract Provides Sisters of Mercy Health System Access to Leading Radiation Therapy Solutions
5. Elekta Launches New Linear Accelerator at 2007 ESTRO to Expand Cancer Treatment Availability
6. Elekta Brings Intelligent Ways to Manage Motion During Cancer Treatment to ESTRO
7. Elekta Displays Complete Volumetric Intensity Modulated Arc Therapy Solutions at ESTRO
8. Elekta Announces New Cancer Care Solutions and Highlights Personalized Efficiency at ASTRO 2007
9. Elekta Announces Elekta Infinity - a New System for Faster and More Precise Treatment of Cancer Tumors
10. Beaumont Hospital, Royal Oak Treats Its First Patients With Elekta Axesse
11. Elekta Showcases Stereotactic Systems for Cancer Care at Astro 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... Mich. , March 27, 2015  Neogen Corporation ... LLC, has adopted a prearranged trading plan in accordance ... Herbert , Chairman and CEO of Neogen Corporation, is ... of Neogen Corporation common stock. Herbert does ... disclosure was appropriate. The filing is only for a ...
(Date:3/27/2015)... March 27, 2015 WuXi PharmaTech (Cayman) ... R&D capability and technology platform company serving the ... today that an Investigational New Drug (IND) application ... rheumatoid arthritis has been accepted for review by ... In September 2012, MedImmune, the global ...
(Date:3/26/2015)... PRC Clinical, a Silicon-Valley based ... and executive appointments effective immediately. , Mike Catelani will ... member of the Board of Directors. Daniel Head is ... Dowden will assume the position of Senior Director of ... Officer (COO), has been appointed to the position of ...
(Date:3/26/2015)... and CINCINNATI , March ... (LSE: SHP, NASDAQ: SHPG ) and Cincinnati ... broad research collaboration for rare diseases. The goal of ... therapies to treat rare diseases with high unmet ... with Cincinnati Children,s research expertise. As a nationally ...
Breaking Biology Technology:Neogen CEO adopts 10b5-1 Trading Plan 2Investigational New Drug Application for WuXi MedImmune's Monoclonal Antibody Accepted for Review by CFDA 2Investigational New Drug Application for WuXi MedImmune's Monoclonal Antibody Accepted for Review by CFDA 3PRC Clinical Announces Key Management Appointments and Launches East Coast Operations 2PRC Clinical Announces Key Management Appointments and Launches East Coast Operations 3Shire and Cincinnati Children's Establish Rare Disease Research Collaboration 2Shire and Cincinnati Children's Establish Rare Disease Research Collaboration 3Shire and Cincinnati Children's Establish Rare Disease Research Collaboration 4Shire and Cincinnati Children's Establish Rare Disease Research Collaboration 5
... 27 Mediatech, Inc. is settling,into their brand ... land,in Prince William County. Right down the road ... joins other,biotechnology and technology companies, including ATCC in ... The brand new manufacturing plant has been ...
... Amended the Design of the Ofatumumab Pivotal Study in, ... ... 81, COPENHAGEN, September 27 Genmab A/S (OMX:,GEN) announced ... study,of ofatumumab (HuMax-CD20(R)) in rituximab refractory follicular,non-Hodgkin,s lymphoma (NHL) to ...
... for October, JACKSONVILLE, Fla., Sept. 27 ... announced today that its,performance/vitality beverage product, AQUISS(TM), will ... to the Oregon border. 7-Eleven,plans a launch of ... sampling campaign to acquaint 7-Eleven,s customers with the,technology ...
Cached Biology Technology:Mediatech Moves to Prince William County Innovation Park 2Genmab Amends Ofatumumab Pivotal Study in NHL to Single Arm Study 2Genmab Amends Ofatumumab Pivotal Study in NHL to Single Arm Study 3Phlo Affiliate Reports AQUISS to be Sold in 450 7-Eleven Stores 2
(Date:3/16/2015)... 2015 Between 16 and ... groundbreaking innovations in biometric identification at the CeBIT ...      (Photo: http://photos.prnewswire.com/prnh/20150316/735333 ) ... well at the forefront: the company,s all new ... Germany . BiometricGate is the ...
(Date:3/12/2015)... WINSTON-SALEM, N.C. , March 12, 2015 ... afternoon at Brenner Children,s Hospital, part of Wake Forest ... an outreach initiative for the 2015 ACC Men,s Basketball ... taking pictures with them and getting their autographs. ... Wake Forest Baptist. It is the only children,s hospital ...
(Date:3/12/2015)... 2015 WHEN:Tuesday, March 17, 2015 at 11:00 ... . SPEAKERS: , Frost & Sullivan Measurement & ... Biometric companies must plan for ... different markets and industries. This is especially true ... Join Frost & Sullivan,s upcoming ...
Breaking Biology News(10 mins):DERMALOG Presents its Latest Biometric Innovations at the Hannover CeBIT Exhibition, 16 - 20 March 2015 2DERMALOG Presents its Latest Biometric Innovations at the Hannover CeBIT Exhibition, 16 - 20 March 2015 3Biometrics Key to Future Growth in Healthcare, Retail and Financial Markets 2Biometrics Key to Future Growth in Healthcare, Retail and Financial Markets 3
... September 11, 2012 BiOptix announced continued support of the ... 2012, a leading life sciences showcase event in ... "BiOptix continues to believe in the goals and ... Rick Whitcomb, President and CEO of BiOptix.   "As ...
... a crow and it,ll remember you for years. Crows and ... with negative, as well as positive, feelings. The way the ... also appear to share, according to new research being published ... together are not unlike those that work together in mammals, ...
... found a way to prevent inflammation and bone loss ... of the enzyme GSK3b, which plays an important role ... of UofL School of Dentistry researcher David Scott, PhD, ... journal Molecular Medicine . The finding not only ...
Cached Biology News:BiOptix Participates in Leading Life Sciences Event BioWest 2012 2Crows react to threats in human-like way 2Crows react to threats in human-like way 3
... Affinity Life Sciences can provide custom microplate coating using ... washes a variety of plate formats. We can also accommodate ... volume range of 0.5-320 L):, , ... 96 well microplate, ...
...
... first biological reagent that eliminates ... not just by inhibiting growth. ... agent that can be used ... The cytotoxicity of Mynox is ...
Mynox is intended for research use only. Mynox is used for the elimination of Mycoplasma and Acholeplasma in cell and virus cultures, and other biologicals....
Biology Products: